Rani Therapeutics Inc.

NASDAQ: RANI · Real-Time Price · USD
0.55
-0.01 (-1.22%)
At close: Aug 15, 2025, 3:58 PM
0.55
0.00%
After-hours: Aug 15, 2025, 07:04 PM EDT

Rani Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-56.58M -33.97M -63.34M -8.33M
Depreciation & Amortization
1.03M 822K 548K 497K
Stock-Based Compensation
16.03M 19.01M 15.78M 22.59M
Other Working Capital
-827K -1.54M 346K -3.97M
Other Non-Cash Items
4.57M -34.96M -10K -43.58M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-544K -2.14M 509K -3.43M
Operating Cash Flow
-35.5M -51.24M -46.52M -32.24M
Capital Expenditures
-268K -1.23M -1.62M -506K
Cash Acquisitions
n/a n/a -851K n/a
Purchase of Investments
-58.72M -73.26M -73.82M n/a
Sales Maturities Of Investments
77.55M 104.35M 3M n/a
Other Investing Acitivies
1.25M n/a 851K n/a
Investing Cash Flow
19.81M 29.86M -72.44M -506K
Debt Repayment
-5M n/a 29.57M -2.85M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-47K -162K -886K 26K
Financial Cash Flow
13.59M 233K 29M 77.15M
Net Cash Flow
-2.1M -21.14M -89.95M 44.4M
Free Cash Flow
-35.76M -52.47M -48.13M -32.75M